Human TRIB3 Stable Cell Line - U-87 MG

The TRIB3 gene (also known as Tribbles pseudokinase 3) encodes a highly conserved scaffold protein that belongs to the Tribbles pseudokinase family. Although TRIB3 itself lacks intrinsic kinase catalytic activity, it plays a pivotal role as an indispensable intracellular signaling regulator and a key sensor of cellular stress. Under normal physiological conditions, TRIB3 expression is tightly regulated. However, when cells encounter various environmental or intracellular stressors—including endoplasmic reticulum (ER) stress, nutrient deprivation, hypoxia, and oxidative damage—its expression levels are significantly upregulated. TRIB3 functions as a negative regulator of the PI3K/AKT signaling pathway by directly binding to the AKT protein, thereby inhibiting its phosphorylation and subsequent activation. Furthermore, TRIB3 interacts with the ATF4, NF-κB, and MAPK signaling pathways, thereby influencing a wide spectrum of cellular processes, such as glucose homeostasis, insulin sensitivity, cell cycle progression, autophagy, and apoptosis. Given the central role TRIB3 plays at the critical nexus of metabolic regulation and cellular survival, dysregulation of its gene expression is frequently implicated as a key pathogenic factor in numerous human diseases, including Type 2 diabetes, cardiovascular diseases, and various malignancies.

The "Human TRIB3 Stable Cell Line," established within the U-87 MG cellular background, serves as a robust, highly reliable, and standardized in vitro experimental model specifically designed to facilitate in-depth research into this multifunctional pseudokinase. The U-87 MG cell line is a classic and widely utilized human primary glioblastoma cell line, making it an ideal platform for studies in neuro-oncology and brain tumor research. Through the application of advanced gene transduction and screening technologies, this stable cell line has been successfully engineered to achieve sustained and stable expression of the human TRIB3 gene. This consistent and stable pattern of gene expression provides researchers with an ideal experimental platform for conducting a diverse range of downstream applications and investigations. Specifically, the "human TRIB3 stable cell line"—constructed against the background of the U-87 MG cell line—is widely utilized to comprehensively elucidate how the TRIB3 protein, through specific molecular mechanisms, drives pathological processes such as the initiation and progression of glioblastoma, as well as tumor infiltration and metastatic dissemination. Furthermore, this cell line serves as a critical resource in the fields of drug discovery and high-throughput drug screening.